2014 Annual Meeting | 3HC.012 - Sleep Principles Applied to Neurological Disease

Date Monday 04/28/14

Time 01:00 PM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Half-Day Course

Director(s) Marcel Hungs, MD, PhD, FAAN

Topic(s)

Learning Objectives Participants should be able to: understand the importance of sleep to brain function; be able to identify patients with neurologic disorders who have sleep issues; and apply sleep and neurologic principles to sleep complaints.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Tracks Subspecialty in Focus

Recommended Audience Other, Trainee, General Neurologist, Specialist Neurologist, Non-neurologist

Teaching Styles Case-based, Didactic

Event Timeline
01:00 PM - 01:35 PM		Not Again - Neurologic Approach to Insomnia Charlene Gamaldo, MD, FAAN
01:35 PM - 02:10 PM		Orexin/Hypocretin Dysfunction and Narcolepsy: Stuck in the Revolving Door Between Wake and Sleep Marcel Hungs, MD, PhD, FAAN
02:10 PM - 02:50 PM		Sleep-related Respiratory Disorders in Neurologic Diseases: An Update Clete A. Kushida, MD, PhD
02:50 PM - 03:05 PM		Break
03:05 PM - 03:45 PM		A Marker and a Treatment Opportunity: Sleep in Neurodegenerative Disorders Ronald Postuma, MD
03:45 PM - 04:25 PM		Iron, Opioids, and Dopamine: What Therapies Tell Us About RLS David B. Rye, MD, PhD
04:25 PM - 05:00 PM		Baby-Baby: Update in Pediatric Sleep Phillip L. Pearl, MD, FAAN

Faculty Disclosures
Marcel Hungs, MD, PhD, FAAN	No disclosure on file
Charlene Gamaldo, MD, FAAN	Dr. Gamaldo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for johns hopkins. Dr. Gamaldo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Idorsia. The institution of Dr. Gamaldo has received research support from NIH/NIMH/NIDA/NINDS. Dr. Gamaldo has received publishing royalties from a publication relating to health care.
Clete A. Kushida, MD, PhD	Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avadel. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Kushida has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for XW Pharma, Inc.. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zephyr Sleep Technologies. Dr. Kushida has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vivos. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerebra. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck & Co., Inc.. Dr. Kushida has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for State of Arizona. Dr. Kushida has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Browne George Ross, LLP. The institution of Dr. Kushida has received research support from AmCAD, Philips-Respironics, Asate, Syneos Health, Inspire. Dr. Kushida has received publishing royalties from a publication relating to health care.
Phillip L. Pearl, MD, FAAN	Dr. Pearl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Pearl has received publishing royalties from a publication relating to health care. Dr. Pearl has received publishing royalties from a publication relating to health care. Dr. Pearl has received publishing royalties from a publication relating to health care. Dr. Pearl has received publishing royalties from a publication relating to health care.
Ronald Postuma, MD	Dr. Postuma has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche, Biogen, Takeda, Theranexus, GE, Jazz, Curasen, Paladin, Inception Sciences, Phytopharmics, Vaxxinity, Merck. Dr. Postuma has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen/Partners. The institution of Dr. Postuma has received research support from CIHR, Weston Foundation, Webster Foundation, Roche, MJFF, Parkinson Canada, FRSQ, NIH.
David B. Rye, MD, PhD	No disclosure on file